| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Aklog Lishan | Chairman and CEO, Director | 360 MADISON AVENUE, 25TH FLOOR, NEW YORK | /s/ Michael A. Gordon, by power of attorney | 02 Oct 2025 | 0001665074 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PAVM | Common Stock | Award | $0 | +150,000 | +191% | $0.000000 | 228,418 | 30 Sep 2025 | Direct | F1 |
| holding | PAVM | Common Stock | 154 | 30 Sep 2025 | By daughter | ||||||
| holding | PAVM | Common Stock | 152 | 30 Sep 2025 | By son | ||||||
| holding | PAVM | Common Stock | 297,105 | 30 Sep 2025 | By Pavilion Venture Partners LLC | F2 | |||||
| holding | PAVM | Common Stock | 1,333 | 30 Sep 2025 | By HCFP/AG LLC | F3 |
| Id | Content |
|---|---|
| F1 | Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
| F2 | Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and therefore has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein. |
| F3 | Dr. Aklog is a co-manager of HCFP/AG LLC, and therefore has joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein. |